Browse

The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication

Cited 74 time in Web of Science Cited 83 time in Scopus
Authors
Kim, Mi Na; Kim, Nayoung; Lee, Sang Hyup; Park, Young Soo; Hwang, Jin-Hyeok; Kim, Jin-Wook; Jeong, Sook-Hyang; Lee, Dong Ho; Kim, Joo Sung; Jung, Hyun Chae; Song, In Sung
Issue Date
2008-07-31
Publisher
Wiley-Blackwell
Citation
Helicobacter. 2008 ;13(4):261-8.
Keywords
AdolescentAdultAgedAged, 80 and overAmoxicillin/administration & dosage/adverse effectsBreath TestsClarithromycin/administration & dosage/adverse effectsDrug Therapy, CombinationFemaleHelicobacter Infections/*drug therapy/microbiologyHelicobacter pylori/*isolation & purificationHumansMaleMiddle AgedProbiotics/*therapeutic useProspective StudiesProton Pump Inhibitors/*administration & dosage/adverse effectsYogurt/*microbiology
Abstract
BACKGROUND: This study was performed to evaluate whether the addition of probiotics to proton pump inhibitor (PPI)-based triple therapy increases the likelihood of successful Helicobacter pylori eradication. MATERIALS AND METHODS: Three hundred and forty-seven H. pylori-infected patients were randomized into a triple-plus-yogurt group (yogurt group, n = 168) or a triple-only group (control group, n = 179). Triple therapy consisted of PPI b.i.d., clarithromycin 500 mg b.i.d., and amoxicillin 1 g b.i.d. for 7 days. Yogurt group received triple therapy for 1 week and one bottle of Will yogurt per day for at 3 weeks, starting on the first day of triple therapy. Will yogurt (a Korean brand) contains Lactobacillus acidophilus HY2177, Lactobacillus casei HY2743, Bifidobacterium longum HY8001, and Streptococcus thermophilus B-1. (13)C-urea breath test was performed at least 4 weeks after completion of triple therapy. Eradication rates, compliances, and adverse events were compared. RESULTS: By intention-to treat analysis the H. pylori eradication rates in the yogurt group 79.2% (133 of 168) was similar to that in the control group 72.1% (129 of 179) (p = .124). However, by per-protocol (PP) analysis, the eradication rate in the yogurt group, 87.5% (133 of 152) was higher than that in the control group, 78.7% (129 of 164) (p = .037). Common adverse events were metallic taste (11.8%) and diarrhea (8.6%). The frequency of adverse effects in the yogurt group 41.1% (69/168) were higher than in the control group, 26.3% (47 of 179) (p = .003). However, most adverse events were mild to moderate in intensity, and the severities of adverse effects were similar in both groups (p = .401). CONCLUSIONS: The addition of Will yogurt to triple therapy did not reduce the side-effects of triple therapy. But it increased the H. pylori eradication rate by PP analysis, encouraging more research in this field.
ISSN
1523-5378 (Electronic)
Language
English
URI
https://hdl.handle.net/10371/62368
DOI
https://doi.org/10.1111/j.1523-5378.2008.00601.x
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse